Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 93 of the 95 references it cites were found in a registry or an index; none of the 66 sources its claims cite is checked for support yet.

International Committee on Mental Health in Cystic Fibrosis: Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus statements for screening and treating depression and anxiety.

Open access

Abstract

Studies measuring psychological distress in individuals with cystic fibrosis (CF) have found high rates of both depression and anxiety. Psychological symptoms in both individuals with CF and parent caregivers have been associated with decreased lung function, lower body mass index, worse adherence, worse health-related quality of life, more frequent hospitalisations and increased healthcare costs. To identify and treat depression and anxiety in CF, the CF Foundation and the European CF Society invited a panel of experts, including physicians, psychologists, psychiatrists, nurses, social workers, a pharmacist, parents and an individual with CF, to develop consensus recommendations for clinical care. Over 18 months, this 22-member committee was divided into four workgroups: Screening; Psychological Interventions; Pharmacological Treatments and Implementation and Future Research, and used the Population, Intervention, Comparison, Outcome methodology to develop questions for literature search and review. Searches were conducted in PubMed, PsychINFO, ScienceDirect, Google Scholar, Psychiatry online and ABDATA by a methodologist at Dartmouth. The committee reviewed 344 articles, drafted statements and set an 80% acceptance for each recommendation statement as a consensus threshold prior to an anonymous voting process. Fifteen guideline recommendation statements for screening and treatment of depression and anxiety in individuals with CF and parent caregivers were finalised by vote. As these recommendations are implemented in CF centres internationally, the process of dissemination, implementation and resource provision should be closely monitored to assess barriers and concerns, validity and use.

Overview

CoChat Summary

TL;DR

This consensus paper recommends annual screening for depression and anxiety in people with cystic fibrosis (CF) and parent caregivers, followed by clinical assessment and stepped treatment when symptoms are elevated. It was developed by a 22-member international committee that reviewed 344 articles and finalized 15 recommendation statements.

Key findings

  • A recent study across 9 countries screened 6,088 CF patients ages 12 through adulthood and 4,102 parents; elevated depression was found in 10% of adolescents, 19% of adults, 37% of mothers, and 31% of fathers, while anxiety was found in 22%, 32%, 48%, and 36%, respectively.
  • Across the literature, depression prevalence ranged from 8% to 29% in children/adolescents and 13% to 33% in adults; anxiety in adults ranged from 30% to 33%; caregiver depression scores ranged from 20% to 35%.
  • The committee finalized 15 guideline recommendation statements after reviewing 344 articles and using an 80% acceptance threshold for each statement.
  • The paper recommends annual screening with the PHQ-9 and GAD-7 for adolescents and adults with CF, and at least one primary caregiver of children with CF, followed by clinical assessment and treatment based on diagnosis rather than screening alone.

Methods

  • Consensus guideline development by a 22-member multidisciplinary committee of international experts, parents of individuals with CF, and an adult with CF, organized into four workgroups: Screening; Psychological Interventions; Pharmacological Treatments; and Implementation/Future Research.
  • Literature searches used PICO questions and multiple databases (PubMed, PsychINFO, ScienceDirect, Google Scholar, Psychiatry Online, ABDATA), limited to English-language sources from 1960–2015; 21,756 references were retrieved, 980 abstracts/books reviewed, and 344 articles selected for in-depth review.
  • Recommendation statements were drafted, reviewed by the full committee, and anonymously voted on until each reached at least 80% acceptance; a preliminary manuscript also received public comment from CF clinical, parent, and patient communities in Europe and the USA.

Limitations

  • The paper states that there was minimal research specifically examining treatment of depression and anxiety in CF, and a Cochrane review found no controlled studies of interventions for CF patients or parent caregivers.
  • The authors note limited evidence for screening and treatment in children under age 7, and limited guidance for routine screening of children below age 12.
  • Evidence from this paper is consensus-based and drawn largely from existing guidelines and indirect evidence rather than CF-specific randomized trials; this is evident from the text.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1136/thoraxjnl-2015-207488

Cites

93 of 93 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 A flexible, stepped-care model for assessing and treating depression and anxiety.
Figure 1 A flexible, stepped-care model for assessing and treating depression and anxiety.CC BY-NC · PubMed Central
Figure 2 Screening and treatment of depression and anxiety: algorithm for individuals with cystic fibrosis (CF) (ages 12–adulthood). CBT, cognitive behavioural therapy; GAD-7, Generalised Anxiety Disorder 7-item Scale; IPT, interpersonal therapy; PHQ-9, Patient Health Questionnaire 9; SSRI, selective serotonin reuptake inhibitor.
Figure 2 Screening and treatment of depression and anxiety: algorithm for individuals with cystic fibrosis (CF) (ages 12–adulthood). CBT, cognitive behavioural therapy; GAD-7, Generalised Anxiety Disorder 7-item Scale; IPT, interpersonal therapy; PHQ-9, Patient Health Questionnaire 9; SSRI, selective serotonin reuptake inhibitor.CC BY-NC · PubMed Central
Figure 3 Screening and treatment of depression and anxiety: algorithm for parents/caregivers. CBT, cognitive behavioural therapy; GAD-7, Generalised Anxiety Disorder 7-item Scale; IPT, interpersonal therapy; PHQ-9, Patient Health Questionnaire 9.
Figure 3 Screening and treatment of depression and anxiety: algorithm for parents/caregivers. CBT, cognitive behavioural therapy; GAD-7, Generalised Anxiety Disorder 7-item Scale; IPT, interpersonal therapy; PHQ-9, Patient Health Questionnaire 9.CC BY-NC · PubMed Central

Verification

Claims the paper makes

0 Valid · 5 Not valid · 48 Not checked · 21 Own results and interpretations

26 more claims

Create a free account to see all 74 claims and every source verdict.

See all claims — free account
  • Probably not a substantial claim. 32
  • It may state two separate claims as one. 19

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 95 references

Cited by

See all 465

Metadata

Authors
Quittner, A. L., Abbott, J., Georgiopoulos, A. M., Goldbeck, L., Smith, B., Hempstead, S. E., Marshall, B., Sabadosa, K. A., & Elborn, S.
Affiliations
  • University of Miami (US)
  • University of Lancashire (GB)
  • Massachusetts General Hospital (US)
  • University Hospital Ulm (DE)
  • State University of New York (US)
  • Dartmouth College (US)
  • Cystic Fibrosis Foundation (US)
Corresponding author
Quittner, Alexandra L
Venue
Thorax
Publisher
BMJ
Published
2015-10-09
Volume
71
Issue
1
Pages
26-34
ISSN
  • 0040-6376 (ISSN-L)
  • 1468-3296
OpenAlex
W2210324311
Cited by
465
References
95
Citations by year
2026: 34 · 2025: 35 · 2024: 47 · 2023: 52 · 2022: 55 · 2021: 51 · 2020: 56 · 2019: 40 · 2018: 34 · 2017: 28 · 2016: 30 · 2015: 1
FWCI
21.64
Type
journal article
Language
en
Open access
Licence
cc-by-nc
Locations
  • Thorax (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • CLOK (University of Central Lancashire) (acceptedVersion)
  • Spiral (Imperial College London) (submittedVersion, other-oa)
Topics
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Cystic Fibrosis Research Advances
  • Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
Keywords
cystic fibrosis, depression, anxiety, psychological distress, screening, pharmacotherapy, psychological intervention, parental caregivers, consensus recommendations, health-related quality of life
MeSH terms
Mental Disorders, Cystic Fibrosis, Humans, International Cooperation, Quality of Life, Societies, Medical, Caregivers, Practice Guidelines as Topic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: International Committee on Mental Health in Cystic Fibrosis: Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus statements for screening and treating depression and anxiety. https://app.cochat.ai/papers/10.1136/thoraxjnl-2015-207488
The paper
Quittner, A. L., Abbott, J., Georgiopoulos, A. M., Goldbeck, L., Smith, B., Hempstead, S. E., Marshall, B., Sabadosa, K. A., & Elborn, S. (2016). International Committee on Mental Health in Cystic Fibrosis: Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus statements for screening and treating depression and anxiety. Thorax. https://doi.org/10.1136/thoraxjnl-2015-207488

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.